Chuck Rosenberg, the troubled agency’s new administrator, will reportedly spend less time on marijuana enforcement. But whether he’ll reclassify it as less dangerous is another matter.
News that a Canadian company acquired 51 percent of a Santa Fe medical marijuana company is sparking fears about how foreign investments in the industry may harm patients.
The mention of Rosie O’Donnell’s marijuana use in her child custody case reinforces the stigma around pot and parenting—one that puts even those who use it medicinally at risk.
The Lone Star State did not decriminalize marijuana Tuesday. A Texas drug activist on the anti-marijuana ways of the Deep South.
Valued at upwards of $35 million, the new legal weed market has cultivated an ambitious group of ganjapreneurs. Why African Americans aren’t among them.
The burgeoning market for pet organ transplants—specifically kidneys—has gone global. Inside a start up that’s transforming the animal health industry.
In 2008, San Francisco’s decriminalization drive went down in flames over donors’ fears of being outed. So proponents formed a nonprofit—and took their new lawsuit funding drive online.
It’s on the WHO’s list of essential medicines, and is invaluable in developing countries. So why is the UN discussing increased regulation of ketamine?
A lot of restaurants charge more for their gluten-free menus. Now, a lawsuit says that goes against the Americans with Disabilities Act.
Popping an ibuprofen after a workout or for a headache seems safe, right? Recent research shows the drug could contribute to leaky gut syndrome and celiac disease.